AstraZeneca inks $245 million deal with Cellectis for rare diseases
HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.
HQ Team November 1, 2023: The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters.
HQ Team October 31, 2023: The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due.
By Dr K. Leelamoni October 31, 2023: During an annual family temple festival, celebrated at my ancestral home in the southern Indian state.
HQ Team October 30, 2023: Researchers at the Indian Institute of Science Education and Research Bhopal (IISER) have developed a transparent biomedical adhesive.
HQ Team October 30, 2023: GSK plc has announced significant findings from a phase III trial trial for Jemperli (dostarlimab), a potential treatment for.
HQ Team October 30, 2023: Researchers have unraveled a critical mechanism involving the dynein protein, shedding light on how it aids the spread.
HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.
HQ Team October 28, 2023: A recent study conducted by a team of researchers from Denmark, the Netherlands, and the United Kingdom challenges.
The World Health Organisation says that each year there are an estimated 374 million new infections with 1 of 4 curable STIs: chlamydia,.